Could CBD oceanic be useful in the fight versus resistant bacterial pressures? The arise from the University of Queensland in Australia suggest that it is possible. But before analyzing the research study in depth, it works to understand the development of the relationship between bacteria and prescription antibiotics.

Since the advanced discovery of penicillin by Alexander Fleming in 1928, prescription antibiotics have actually been a vital tool in the fight versus bacteria and infections. And although we still use the exact same proven approaches today, bacteria have actually developed. When exposed to prescription antibiotics, particular bacteria, fungi and parasites are able to adjust and cancel the effectiveness of the drug by establishing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to take place anyway, as the hereditary code for bacteria changes with time. Nevertheless, it is believed that the overuse of prescription antibiotics is a crucial element that speeds up the development of resistant pressures.

According to the World Health Organization, antimicrobial resistance “is an increasingly severe threat to worldwide public health that requires action in all sectors of federal government and in society.” This has led researchers to believe outside the box by attempting to identify compounds that could be helpful in the fight versus harmful bacteria. Among these compounds is cannabidiol (CBD), a cannabinoid discovered in Cannabis sativa.

Researchers are looking for new methods to assault infections and resistant bacteria.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that inner CBD is effective versus Gram-positive bacteria. Strains of Gram-positive bacteria include Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich presented his findings at an annual conference of the American Society for Microbiology. In vitro samples of both kinds of gram-positive bacteria were treated with artificial CBD. The results led Dr. Blaskovich to the conclusion that CBD operates at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He likewise discovered that CBD appeared to work against gram-positive pressures of resistant bacteria, which numerous traditional prescription antibiotics are starting to fail.

” In specific, the activity was chosen versus the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low tendency to induce resistance and was active versus MRSA biofilms. “

The team likewise performed another research study utilizing topical CBD to treat a skin infection in mice. Once again, although the results were positive, CBD did not appear to get rid of the infection, however merely to lower the variety of bacterial cells.

Could CBD end up being an antibiotic?

While it is easy to hail this work as a significant development in the antibacterial capabilities of CBD, it is too soon to give up on penicillin.

Although it is believed that the effectiveness of CBD could come from the way it attacks the biofilm surrounding bacterial cells, the authors are still not sure of the mechanism of action of CBD. They likewise did not think twice to mention the drawbacks of the research study. Dr. Blaskovich explained that given that the results remain in the initial phases, it is far too early for individuals to start treating their CBD infections themselves.

The research study was likewise performed in vitro (outside the human body), and there is a risk that the results of medical trials will not be the same. Numerous compounds have actually revealed antibacterial efficacy in petri meals, however then failed at this crucial phase. It needs to likewise be pointed out that the two research studies were performed in cooperation with Botanix Pharmaceuticals Ltd, a pharmaceutical business focusing on topical CBD products.

Nevertheless, this research study could be a crucial advance for CBD and the fight versus antimicrobial resistance.

Scroll to top